Wu et al. validated MMPs as therapeutic targets for prostate cancer metastasis by demonstrating inhibition of DU-145 and PC-3 prostate cancer cell migration and invasion upon transfection with miRNA-143, a miRNA that directly targets MMP-13 [110]. Here, MMP13 is linked to prostate carcinoma.